Iron Sequestration: A Key Immune Defense Mechanism

Your immune system fights infection not only by attacking invaders directly but also by starving them of a nutrient they cannot live without: iron. This strategy, often called nutritional immunity, involves a coordinated effort to pull iron out of the bloodstream, lock it inside storage proteins, and deny it to bacteria, fungi, and even some viruses. The concept reframes a familiar mineral as a battlefield resource, and the molecular tug-of-war between host and pathogen over iron turns out to be one of the most ancient and consequential contests in biology.

Why Iron Is Worth Fighting Over

Iron is essential for nearly all living organisms. It sits at the active center of enzymes involved in DNA replication, energy production, and oxygen transport. For an invading microbe trying to multiply rapidly inside your body, access to iron is often the single biggest bottleneck. The human body contains several grams of iron, but almost none of it floats around freely. Most is bound inside hemoglobin in red blood cells, stored in the protein ferritin, or attached to transport proteins in the blood. This tight binding is not accidental. Keeping free iron vanishingly scarce is itself an immune strategy, because any pathogen that cannot pry iron loose from these proteins has trouble growing.

The Hepcidin-Ferroportin Gatekeeping System

The body’s master switch for iron distribution is a hormone called hepcidin, produced mainly by the liver. Hepcidin works by targeting ferroportin, the only known protein that exports iron out of cells and into the bloodstream. When hepcidin binds ferroportin, the exporter is pulled inside the cell and broken down, trapping iron within the cell and keeping it out of circulation.

During an infection, inflammatory signals ramp up hepcidin production. The result is a rapid drop in the amount of iron circulating in your blood, a state sometimes called hypoferremia. This is not a malfunction. It is a deliberate defensive maneuver: by collapsing blood iron levels, the body cuts off the supply that bloodborne pathogens need to thrive.

This mechanism is central to how the body regulates iron metabolism. Hepcidin binds ferroportin, causing its internalization and degradation, which leads to iron sequestration within ferroportin-expressing cells such as macrophages and intestinal cells.¹ The effect is systemic: iron absorption from food drops, recycling of iron from old red blood cells slows, and the pathogen’s dinner table empties.

Specialized Proteins That Scavenge Iron

Beyond the hepcidin system, the body deploys several proteins whose job is to grab iron or iron-containing molecules before pathogens can use them. Two of the most important are lactoferrin and lipocalin-2.

Lactoferrin is a glycoprotein found in high concentrations in breast milk, tears, saliva, and nasal secretions, the exact locations where your body first encounters invading microbes. It has a strong ability to chelate (bind) free iron ions, pulling them out of the environment where bacteria would otherwise scavenge them. By chelating free iron, lactoferrin reduces oxidative stress and limits the growth mechanisms that depend on iron availability.² Its presence in breast milk is one reason why breastfed infants tend to be more resistant to certain gut infections: the lactoferrin is actively starving bacteria in the infant’s digestive tract.

Lipocalin-2, also known as neutrophil gelatinase-associated lipocalin (NGAL) or siderocalin, takes a different approach. Rather than binding free iron directly, it targets siderophores, the small iron-stealing molecules that bacteria secrete. Lipocalin-2 is a host defense protein induced by the innate immune response that sequesters iron-loaded bacterial siderophores, preventing bacteria from reclaiming the iron they worked to capture.³ Structural studies have shown that lipocalin-2 can bind catecholate-type siderophores, which are among the most common iron-scavenging molecules produced by bacteria like E. coli and related species.⁴

Lipocalin-2 is not without downsides. As a critical component of the innate immune response, it can also cause collateral damage. Research has shown that it can trigger adverse inflammatory effects in host tissues, including increased oxidative stress in heart cells.⁵ This is a recurring theme in iron sequestration: the defense is powerful but comes at a cost to the host.

Iron Stripping Inside the Immune Cell

When a macrophage engulfs a bacterium, the microbe ends up trapped inside a compartment called the phagosome. The macrophage does not just wait for the bacterium to die. It actively strips the phagosome of iron using a transporter protein called Nramp1 (also known as Slc11a1). This protein pumps iron, manganese, and cobalt out of the phagosome and into the macrophage’s own cytoplasm, denying the trapped pathogen the metals it needs to survive.

Experiments have shown that Nramp1 transport depends on acidic pH and works down the proton gradient that the macrophage creates inside the phagosome. The protein appears to be particularly efficient at transporting manganese, another metal some bacteria rely on, in addition to iron.⁶ Individuals with certain variants of the Nramp1 gene have historically shown increased susceptibility to intracellular pathogens like the bacteria that cause tuberculosis, which underlines how critical this phagosomal iron-draining step is.

Macrophages facing a fungal threat mount a similar response. Computational modeling of macrophages exposed to Aspergillus (the mold that causes aspergillosis) found an overwhelming iron-hoarding response beginning just two to four hours after exposure to the fungus. The macrophages ramped up proteins that import iron and simultaneously shut down ferroportin, the protein that would export iron back out.⁷ The macrophage, in other words, becomes an iron vault: everything comes in, nothing goes out.

How Pathogens Fight Back

Pathogens have not sat idle while the immune system evolved these iron-withholding strategies. The most widespread countermeasure is the production of siderophores, small molecules with an extremely high affinity for iron. Bacteria secrete siderophores into their surroundings, where the molecules grab iron from host proteins and environmental stocks, then shuttle it back to the bacterium through specialized receptors on the cell surface.⁸

This sets up a direct molecular contest. The host immune system secretes lipocalin-2 to intercept iron-loaded siderophores before they can be taken back up by the bacterium. But some bacteria have evolved siderophores that lipocalin-2 cannot recognize. Certain species carry the iroA gene cluster, which modifies the standard siderophore enterobactin by adding sugar molecules to its structure. The resulting modified siderophore, called salmochelin, slips past lipocalin-2’s grip.⁹ Bacteria that produce these stealth siderophores, including Salmonella and certain strains of E. coli, tend to be more virulent in part because they can dodge this immune defense. In response, the host secretes lipocalin-2 to block standard siderophores, and some bacteria counter by producing lipocalin-2-resistant versions, creating an ongoing evolutionary arms race.¹⁰

Other pathogens skip siderophores entirely and steal iron straight from host transport proteins. Several important human pathogens that live in the upper respiratory or genitourinary tracts rely on surface receptor proteins that latch directly onto transferrin and lactoferrin, the host’s own iron carriers, and strip iron from them.¹¹ These bipartite transferrin receptors consist of two components that together recognize and bind host transferrin with enough specificity to exploit it as a dedicated iron source.¹² Bacteria like Neisseria meningitidis and Haemophilus influenzae are among those that use this strategy, and the fact that these receptors are surface-exposed makes them potential vaccine targets.¹³

When Iron Overload Becomes Dangerous

If iron sequestration is a defense, then conditions that flood the body with excess iron amount to a lowered drawbridge. The clearest example is hereditary hemochromatosis, a genetic condition in which hepcidin production is deficient and the body absorbs and stores far more iron than it needs. People with hemochromatosis face dramatically higher risk from so-called siderophilic bacteria, organisms whose virulence is supercharged by excess iron.

Vibrio vulnificus is the poster child. This marine bacterium causes fulminant sepsis with mortality higher than 50% in susceptible patients, including those with hemochromatosis and other iron overload conditions, but it does not cause severe illness in healthy individuals.¹⁴ Experiments in mice confirmed that hepcidin deficiency leads to increased bacterial counts in the bloodstream and decreased survival after Vibrio vulnificus infection, effects that could be partly reversed by depleting iron through diet.¹⁵ Yersinia enterocolitica, a foodborne pathogen, shows a similar pattern of enhanced virulence in iron-overloaded hosts.

This has practical implications for iron supplementation. Giving iron to someone whose body is already fighting an infection can theoretically feed the pathogen. Research in children has explored this concern: one study found that iron-deficient children had roughly half the odds of acute viral or bacterial infection compared to children with normal iron levels, while children who were clearly iron-replete had about three times the odds of infection.¹⁶ The relationship is not simple enough to say “iron supplements are dangerous,” but it does suggest that the timing and context of supplementation matter, particularly in regions with high infectious disease burden. The body’s decision to lower iron during infection is not a pathology to be corrected; it is a calculated defense.

Iron Sequestration in the Brain

The iron-withholding strategy is not limited to the bloodstream and gut. Microglia, the resident immune cells of the brain, also sequester iron when they detect inflammatory signals. Research has shown that when microglia shift into an inflammatory state, they increase their uptake of iron from both transferrin-bound and non-transferrin-bound sources and actively sequester both extra- and intracellular iron.¹⁷

This makes sense as a protective measure against brain infections, but it creates a problem in chronic neuroinflammatory conditions. If microglia remain activated for months or years, as happens in neurodegenerative diseases, the iron they hoard can accumulate to toxic levels. Excess intracellular iron promotes the formation of reactive oxygen species, which damage neurons. Iron accumulation in the brain has been documented in Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis, suggesting that an immune defense designed for short-term infection fighting can backfire when inflammation becomes chronic.

Cancer Cells and the Iron Economy

Cancer cells are notorious for their appetite for iron. They need it for the same basic reasons bacteria do: rapid DNA replication and energy production require iron-containing enzymes. Tumors exploit the immune system’s iron-handling machinery in ways that undermine immune surveillance. Research has shown that once cells become cancerous, they can divert tumor-infiltrating immune cells to satisfy their iron demand, weakening the immune response at the tumor site.¹⁸

Macrophages that infiltrate tumors can be reprogrammed by the tumor microenvironment to release iron rather than sequester it, essentially flipping their normal defensive behavior. This observation has spurred interest in whether iron chelation or manipulation of the hepcidin-ferroportin axis could be used as part of cancer therapy, though this remains largely experimental.

Iron Chelation as an Antimicrobial Strategy

If starving bacteria of iron works as a natural defense, researchers have asked whether they can amplify the effect with drugs. Iron chelators, compounds that bind and remove iron from solution, have been tested as adjuvants to existing antibiotics, with promising results against drug-resistant bacteria.

One research group demonstrated that combining the iron chelator deferasirox with the antibiotic thiostrepton inhibited the growth of clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii, two notoriously resistant hospital pathogens. Individually, the compounds only slowed bacterial growth, but the combinations killed the bacteria outright. Importantly, the team confirmed that the chelators worked through iron sequestration rather than through any direct antibiotic-like activity of their own.¹⁹

Other groups have taken this further by engineering macromolecular iron chelators, polymer-based molecules designed to soak up iron selectively. Conjugates of a high-affinity iron chelator with polyglycerol slowed the growth of Staphylococcus aureus and, when combined with low concentrations of the antibiotic rifampicin, proved effective at killing methicillin-resistant S. aureus (MRSA).²⁰ As antibiotic resistance continues to grow, these chelation-based strategies represent a genuinely different angle of attack, one that mimics and intensifies the body’s own nutritional immunity.

The Gut Microbiome Complication

Iron sequestration gets messy in the gut, because the immune system needs to starve pathogens without also starving the beneficial bacteria that maintain a healthy intestinal ecosystem. The gut microbiome includes hundreds of species that all need iron, and they use many of the same acquisition strategies as pathogens: siderophores, surface receptors, and scavenging of host-derived iron sources. Recent work has explored how various iron acquisition strategies are used by the host, commensal organisms, and pathogens to benefit or outcompete each other in the complex gut environment, and has identified microbial species and metabolites that modulate host iron absorption.²¹

Oral iron supplementation, which is among the most commonly prescribed treatments for anemia worldwide, delivers a bolus of iron directly into the gut. Some of that iron is absorbed, but much of it passes into the colon, where it can shift the balance of microbial communities. Certain pathogenic species thrive in iron-rich conditions while beneficial species like lactobacilli, which tend to need less iron, may lose ground. This is one reason why iron supplements sometimes cause gastrointestinal symptoms and why researchers are exploring alternative delivery methods, such as slow-release formulations and iron-fortified foods, that provide iron without flooding the gut lumen.

An Ancient Defense Found Across the Animal Kingdom

Iron withholding is not a recent mammalian innovation. Fruit flies use it too. Research in Drosophila melanogaster demonstrated that a fly protein called Transferrin 1 mediates nutritional immunity through an iron-withholding strategy that mirrors what happens in mammals. Flies with disrupted Transferrin 1 were more susceptible to infection, confirming that the iron limitation strategy is functionally essential and not just a biochemical side effect.²² The finding that insects rely on the same class of iron-transporting proteins for immune defense suggests this strategy predates the split between vertebrates and invertebrates, placing its origins hundreds of millions of years ago.²³

That evolutionary depth helps explain why iron sequestration is so deeply woven into immune function. It is not a boutique defense pathway used by a handful of specialized cells. It is a foundational strategy: ancient, conserved, and deployed at every level from systemic hormone signaling down to the interior of a single phagosome. Pathogens have been evolving counterstrategies for just as long, and the molecular arms race shows no signs of a ceasefire.